Abstract
This chapter describes the recommended routine for follow-up of drug resistant cases during treatment. Directly observed treatment is absolutely indispensable in patients with drug resistant tuberculosis to avoid the development of further resistance due to inadequate adherence. Monthly evaluation should include active search of side effects and adverse reactions through clinical and laboratory studies. Bacteriological follow-up will consist of monthly sputum smears and cultures, and after culture conversion, monthly sputum smears and bimonthly cultures.
Keywords: Hospitalized, Hemoptysis, Isolation, Monitoring, Out-patient, Promoter, Respiratory distress, Risk.